Skip to main content
. 2014 Jan 21;123(10):1512–1515. doi: 10.1182/blood-2013-10-532895

Table 1.

Immunoglobulins rescued from lymphomas of HCV-infected patients do not react with HCV proteins

Patient Isotype Diagnosis Lymphoma response to antiviral therapy VH VL Accession # VH/VL HCV genotype E2661 J6E2 E1E2 NS + Core
101 IgM/k DLBCL ND VH1-69 Vk3-20 KF895775/6 ND Neg ND ND ND
102 IgM/k FL ND VH3-48 Vk1-39 KF895777/8 ND Neg ND ND ND
103 Ig*/k MZL ND VH4-59 Vk3-20 KF895779/80 ND Neg ND ND ND
104 IgM/k DLBCL ND VH1-69 Vk1D-16 KF895781/2 ND Neg ND ND ND
105 IgM/k DLBCL ND VH1-69 Vk3-20 KF895783/4 ND Neg ND ND ND
106 IgM/k NHL ND VH4-59 Vk3-15 KF895785/6 ND Neg ND ND ND
107 IgM/k NA ND VH3-21 Vk1-39 KF895787/8 ND Neg ND ND ND
108 IgM/k NA ND VH4-59 Vk3-15 KF895789/90 ND Neg Neg Neg Neg
109 IgM/k NA ND VH4-34 Vk3-20 KF895791/2 ND Neg Neg Neg Neg
110 IgM/k NA ND VH4-59 Vk3-20 KF895793/4 ND Neg Neg Neg Neg
111 IgG/k NA ND VH1-02 Vk2-30 KF895795/6 ND Neg Neg Neg Neg
112 IgM/k NA ND VH4-34 Vk3-20 KF895797/8 ND Neg Neg Neg Neg
121 IgM/k MALT MZL Yes VH1-69 Vk3-20 KF895799/800 2a/2c Neg Neg Neg Neg
122 IgM/k SMZL No VH4-59 Vk3D-15 KF895801/2 1b Neg Neg Neg Neg
123 IgM/k SMZL Yes VH1-69 Vk3-20 KF895803/4 2a/2c Neg Neg Neg Neg
124 IgM/k MALT MZL Yes VH4-30 Vk3-15 KF895805/6 2a/2c Neg Neg Neg Neg
125 IgM/k SMZL Yes VH3-30 Vk1-8 KF895807/8 2a/2c Neg Neg Neg Neg
126 IgM/k MALT MZL Yes VH1-69 Vk3-20 KF895809/10 1b Neg Neg Neg Neg
127 IgM/k NHL No VH1-69 Vk3-20 KF895811/2 1b Neg Neg Neg Neg

DLBCL, diffuse large B-cell lymphoma; FL, follicular lymphoma; Ig*, undetermined heavy chain; MALT, mucosa-associated lymphoid tissue; MZL, marginal zone lymphoma; NA, not available; ND, not done; Neg, negative; NS + Core, HCV nonstructural + core proteins; SMZL, splenic marginal zone lymphoma.